- Home
- CXAI vs ICU Comparison
CXAI vs ICU Comparison
Compare CXAI & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXAI | ICU |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8M | 15.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CXAI | ICU |
|---|---|---|
| Price | $0.36 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.9M | ★ 3.4M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,222,000.00 | $881,000.00 |
| Revenue This Year | N/A | $691.85 |
| Revenue Next Year | $70.21 | $64.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1195.59 |
| 52 Week Low | $0.35 | $0.23 |
| 52 Week High | $2.54 | $3.07 |
Technical Indicators
Market Signals| Indicator | CXAI | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 32.77 |
| Support Level | $0.37 | $0.23 |
| Resistance Level | $0.41 | $0.28 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 9.08 | 19.24 |
Price Performance
Historical ComparisonAbout CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.